Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of ultrasound called 3D ultrasound imaging to help doctors better diagnose breast tumors. The goal is to see if this advanced imaging method can provide clearer and more accurate pictures of breast masses, which could help in making better treatment decisions.
The trial is open to adult women aged 18 and older who have a breast lesion and are already scheduled for a biopsy, which is a procedure to examine breast tissue. However, women who have had previous breast surgery, breast implants, or are currently pregnant, breastfeeding, or undergoing cancer treatment cannot participate. If you join the study, you can expect to undergo this new imaging technique along with your regular care, and your participation will contribute to important research that could improve breast cancer diagnosis in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult women ≥ 18 years of age.
- • solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other IRB-approved studies)
- • lesion size of 3mm or larger
- Exclusion Criteria:
- • \< 18 years of age.
- • Lacking capacity to consent
- • Pregnant or lactating
- • Receiving cancer therapy such as chemotherapy or radiation therapy
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Shigao Chen, PhD
Principal Investigator
Mayo Clinic
Christine Lee, MD, PhD
Principal Investigator
Mayo Clinic in Rochester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials